| Literature DB >> 35073987 |
Joshua Seun Olajide1,2,3, Zigang Qu1,2, Shunli Yang1,2, Oyeseyi Joshua Oyelade4, Jianping Cai5,6.
Abstract
Apicomplexans are important pathogens that cause severe infections in humans and animals. The biology and pathogeneses of these parasites have shown that proteins are intrinsically modulated during developmental transitions, physiological processes and disease progression. Also, proteins are integral components of parasite structural elements and organelles. Among apicomplexan parasites, Eimeria species are an important disease aetiology for economically important animals wherein identification and characterisation of proteins have been long-winded. Nonetheless, this review seeks to give a comprehensive overview of constitutively expressed Eimeria proteins. These molecules are discussed across developmental stages, organelles and sub-cellular components vis-à-vis their biological functions. In addition, hindsight and suggestions are offered with intention to summarise the existing trend of eimerian protein characterisation and to provide a baseline for future studies.Entities:
Keywords: Antigen; Apicomplexa; Coccidiosis; Eimeria; Parasite; Protein; Secretion
Mesh:
Substances:
Year: 2022 PMID: 35073987 PMCID: PMC8785600 DOI: 10.1186/s13071-022-05159-0
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Major developmental stages of Eimeria. Eimeria life-stages within the host occur once except in merozoite where there can be two or more generations. Only sporulated oocysts are infective and may remain inactive until excystation is activated by enzymatic reaction in the host gut to liberate two to four sporocysts from which sporozoites are released. The sporozoites then transform into merozoites, trophozoites, gametocytes and then oocysts, which are released with host egesta. The distinction between early and late oocysts cannot only be explained away by sporulation as oocysts may remain unsporulted for a long time in the environment. MG: merozoite generation
Fig. 2Workflow for protein identification and characterization. Identification and characterization of Eimeria proteins are carried out by several biochemical, genetic and in silico approaches. Exogenous stimuli can propel parasites to secrete proteins in vitro and subjection of parasite stages to sonication/organellar fractionation can produce parasite lysates. The crude protein components of parasite lysate can be resolved by chromatography (LC/GC) coupled with gel-based techniques (e.g. SDS-PAGE, 2D-PAGE, 2D-DIGE) and then subjected to MS or MS/MS. Commonly used ionization methods in conjunction with MS include MALDI, SELDI and ESI followed by curation of peptide sequences in the database. Besides, parasite lysate can be subjected to quantitative proteomics techniques (e.g. iTRAQ, ICAT, TMT, SILAC) to identify the relative quantity of each characterised protein curated from web-based library screening. Alternatively, specific protein coding genes could be identified, cloned and expressed in bacterial vectors. The recombinant protein is then used to raise antibody in animals with which protein size (from western blotting) and sub-cellular location (by immunolocalisation/immunofluorescence) of protein in parasite stages are determined. Overall, quantitative proteomics techniques give precise, differential expression of proteins and can predict the underlying functional mechanism that may resolve various overlapping functions of several eimerian proteins. It is however notable that very few studies have used quantitative proteomics methods to characterise Eimeria proteins. SDS-PAGE: sodium dodecyl sulphate polyacrylamide gel electrophoresis; 2-DE: two-dimensional gel electrophoresis; 2D-DIGE: two-dimensional differential gel electrophoresis; LC: liquid chromatography; GC: gas chromatography; MS/MS: tandem mass spectrometry; SELDI: surface-enhanced laser desorption/ionization; ESI: electrospray ionization; MALDI-TOF: matrix-assisted laser desorption ionisation time of flight; iTRAQ: isobaric tags for relative and absolute quantification; SILAC: stable isotope labelling by amino acids in cell culture; TMT: tandem mass tag; ICAT: isotope-coded affinity tags
Expression and function of Eimeria proteins
| Speceis | Stages/organelles | Protein | Functions | References |
|---|---|---|---|---|
| Oocyst | OWP13; cystein-rich | Transglutaminase activity* | [ | |
| Oocyst wall formation | ||||
| Oocyst, sporozoite | Apartyl proteinase; 43 kDa | Antigen | [ | |
| UO | LDH, enolase, b-tubulin, kinase Hsp70 | Immunogenes, metabolism | [ | |
| Sporoblast, sporocyst SO, sporozoite | Hsp70, 70 kDa | Stress adaptation | [ | |
| Oocyst | Hsp70 | SC component, chromosome, pairing, disjuction and recombination | [ | |
| Oocysts, Sz | MIC2 | Immunogenic | [ | |
| SO, Sz, Mz, Tz, schizonts | Protein disulphide isomerase (PDI) | Sporulation, adhesion, invasion and development | [ | |
| SO, Sz, Mz | ESP | Rhoptry, PVM, oocyst microgamete development | [ | |
| UO, SO, sporocyst wall | gam 22 | Immunogene | [ | |
| Sporocyst, SO | MOP1 (28.7 kDa) | Unknown | [ | |
| Gametocytep, Sz | MOP2 (30.1 kDa | |||
| UO, SO, Mz | MIC 1 (25.89 kDa) | Immunogenic | [ | |
| Gametocyte | MIC 3 (32.39 kDa) | Antigen | ||
| OU, SO,Sz, Mz, Tz schizont | ECP (25.4 kDa) | Invasion, development merogony | [ | |
| UO, SO | AMA1 | Invasion and development | [ | |
| 2nd merozoites, Sz Sz. Mz, UO, SO | SZ-1; 19 kDa, profiling-like | Parasite maintenance | [ | |
| Sporoblast/sporocyst SO, circumplasm | OWP2,6 | Sporocyst wall formation | [ | |
| Gametocyte, Mz | Cathepsin-L-like peptidase | Endogenous parasite development, immunogenp | [ | |
| Sz and UO | ||||
| Initiate sporulationP | ||||
| Sz, Mz, early oocyst, late oocysts | SAGs | Antigen | [ | |
| RONs | Protein synthesis, antigen | |||
| MIC8 | Metabolism | |||
| Mz | RON2, AMA2& RON5 AMA1& RON4 | Cell communication, invasion, antigen | [ | |
| Oocyst | wp29 and wp33 | Oocyst wall formation oocyst wall hardening | [ | |
| SO, Sz, Mz | ESP; 30 kDa | Interaction with host structural PVM and microgamete protein | [ | |
| UO, SO, Sz, Mz | ECP 25.4 kDa | PVM formation | [ | |
| UO, SO, Sz, Mz | Antigen | [ | ||
| UO, SO, Sz, Mz | ||||
| SO, Sz | Eimepsin/aspartyl proteinase 43-kDa | |||
| SO, Sz | ||||
| SO, Sz | ||||
| SO, Sz | ||||
| Sporocysts, Sz, Mz | ESP (27.9- > 34 kDa) | Sporozoite invasion | [ | |
| Sz Mz | MIC 3 (93.04 kDa) | Immunogene | [ | |
| Sporocyst | Sporocyst wall protein 1 Tyrosine-rich | Sporocyst wall formation | [ | |
| Sz, Mz | MIC 5 (12.18 kDa) | Antigenic | [ | |
| Sz, Mz | MIC 2 | Immunogenic, | [ | |
| Sz, Mz, 1st schizogony | Hsp90 | Host cell invasion, stress intracellular growthp | [ | |
| Sz | SO7* SAG 13, 14 | Invasion antigenic* | [ | |
| Sz, im/mature schizonts | CHP559 | Invasion | [ | |
| Sz conoid | *EF-1α-associated protein | Cytoskeleton, growth, motility, protein turnover, signal transduction, transhydrogenase | [ | |
| Sz apicoplast | 38 kDa Malonyl-CoA acyl-carrier protein transacylase | Fatty acid biosynthesis enzyme, drug target* | [ | |
| Sz, 2ndgeneration Mz | Hsp20.4 | Sporulation, survival response to stress | [ | |
| Sz | ROP1 (73 kDa) with NTE | Inhibit apoptosis, arrest of G0/G1 cell cycle | [ | |
| Sz, Tz, schizont | MIC2 (50 kDa) | Unknown | [ | |
| Sz, Mz | hsp70-like antigens | Antigenic, parasite survival* | [ | |
| Sz | MIC3; 124 kDa | Antigenic, confers immunity | [ | |
| Sz | MIC 3 | Development, invasion | [ | |
| Sz | 100 kDa antigen | Host cell penetration | [ | |
| Sz | IMP1 | Immunogenenic | [ | |
| Sz | p160/p240;19 kDa | (Conserved) antigen | [ | |
| Sz | (Conserved) antigen | |||
| Sz | (Conserved) antigen | |||
| Sz | (Conserved) antigen | |||
| 2nd gen. Mz | 14-3-3, subtilase lactacte | Immunogenic | [ | |
| Gametocytes, inner oocyst wall | WFB 2, Gam 22 | Oocyst structural component | [ | |
| Gametocytes | Gam 52 and 86 | Oocyst wall formation | [ | |
| Sz, Mz and SO | MIC8;100 kDa | Invasion, adhesin immunogene | [ | |
| WFB, macrogametocytes | gam56, 82 (52.45 and 62.45 kDa) | Antigenic, gametocyte differentiation | [ | |
| Sporozoite | EF-2, 14-3-3, transhydrogenase | Common immunogenic antigens | [ | |
| Sz, Mz, PVM, immature schizont | 19 kDa,175aa;serine/threonine protein phosphatase | Drug resistance, invasion* | [ | |
| Sz, schizont, PVM | MIC1; Transmembrane with epitope 1 &CTR | PV formation, parasite development | [ | |
| Sz, Mz, apicoplast macrogametocyte | 35 kDa Enoyl reductase | Type II fatty acid biosynthesis | [ | |
| Sporozoite | Enoyl reductase | Drug target* | [ | |
| UO, SO, Sz | Serpin (45 kDa) serine protease inhibitor | Parasite survival invasion* | [ | |
| Oocyst | Serpin; 48/55 kDa | Invasion development* | [ | |
| Sz, 1st & 2nd generation Mz, gametocyte, UO | MIC2;35.07 kDa | Invasion antigen | [ | |
| 342aa acidic protein | ||||
| Gametocyte, UO, SO | HOWP1; 40, 30 & 23 kDa | Vaccine* | [ |
SC synaptonema complex, UO unsporulated oocyst, SO sporulated oocyst, Sz sporozoite, Mz merozoite, Tz trophozoite, *speculative protein/function, NTE N-terminal extension, Ef-2 elongation factor 2
Fig. 3Protein secretion during invasion by eimerian sporozoite and merozoite. a Sporozoites must navigate the gut lumen until they reach the enterocytic niche with specific receptor(s) such as BCL2-AIEPU for attachment and which in turn stimulate protein secretion and host SG, which are known to function in the secretion of MICs. At the site of invasion, sporozoites first attach to the enterocytes with a sequence of events including formation of MJ and PVM accompanied by protein secretion. AMA2/RON5 contribute to MJ formation as RBs add to the array of acidic protein secretions. b For merozoites, RON4/AMA1 are particularly involved in MJ formation and MICs, ROPs ans proteinase play important roles during the process. Nonetheless, the complexes (AMA-1 and RON4) and (AMA-2 and RON5) may suffice for distinction between swift short-lived merozoites and long-ranging sporozoites. Unlike sporozoites with considerable motility, merozoites invade enterocytes fiercely and locally. The proteins involved during Eimeria invasion are quite different from other Apicomplexa [156] probably because of different host cell receptors and Eimeria's extensive migration in host gut. BCL2-AIEPU: associated athanogene 1 and endonuclease polyU-specific-like receptors; SG: surface glycan